OKYO Pharma reveals update on dry eye disease candidate
Phase 2 study of OK-101 will commence soon as company hopes drug will provide unmet need
Read More
Tag: drug
Investigational atopic dermatitis drug hits late-stage endpoints
There is currently a “critical need” for additional treatment options for atopic dermatitis.
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
